Pro-Dex, Inc. (PDEX)Healthcare | Medical Instruments & Supplies | Irvine, United States | NasdaqCM
61.55 USD
-1.34
(-2.131%) ⇩
(July 13, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | July 11, 2026, 4:09 a.m. EDT
The long-term investment case is exceptionally strong, driven by a dominant multi-year price trajectory that has surged nearly sevenfold over the last nine years, reflecting a massive market reassessment of the company's quality. Fundamentals confirm this re-rating: the business boasts a fortress-like balance sheet with a current ratio of 3.67, robust free cash flow generation, and an impressive 29.8% return on equity, all while maintaining healthy operating margins. While the trailing P/E of 17 appears elevated compared to traditional value metrics, it aligns with the high growth rates and superior profitability metrics, suggesting the market is pricing in a high-quality compounder rather than a distressed asset. The recent earnings beat, despite a temporary stock dip, reinforces the operational strength. In the short term, the setup is constructive but not explosive. The stock is trading well above its 200-day average, indicating a solid trend, yet the recent volatility and the fact that the price is still below the analyst consensus target suggest there is room for further upside without being fully extended. The statistical forecast offers only a weak lean upward, which is appropriate given the low confidence in short-term noise prediction, so the short-term rating remains moderate-high rather than a full-blown momentum play. There is no dividend component to consider; the company has not issued dividends in the last five years, directing all capital toward reinvestment and growth. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.125552 |
| MSTL | 0.167096 |
| AutoETS | 0.173540 |
| AutoARIMA | 0.173540 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 37% |
| H-stat | 1.81 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.024 |
| Excess Kurtosis | 0.69 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 44.63 |
| Revenue per Share | 23.01 |
| Market Cap | 196,514,320 |
| Trailing P/E | 16.96 |
| Forward P/E | 29.88 |
| Beta | 0.02 |
| Profit Margins | 16.08% |
| Website | https://www.pro-dex.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.36037207 |
| Address1 | 2,361 McGaw Avenue |
| All Time High | 70.26 |
| All Time Low | 0.375 |
| Ask | 62.75 |
| Ask Size | 5 |
| Audit Risk | 9 |
| Average Daily Volume10 Day | 98,220 |
| Average Daily Volume3 Month | 54,990 |
| Average Volume | 54,990 |
| Average Volume10Days | 98,220 |
| Beta | 0.018 |
| Bid | 30.0 |
| Bid Size | 10 |
| Board Risk | 7 |
| Book Value | 14.139 |
| City | Irvine |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 7 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 61.55 |
| Current Ratio | 3.67 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 62.945 |
| Day Low | 60.53 |
| Debt To Equity | 44.63 |
| Display Name | Pro-Dex |
| Earnings Growth | 0.224 |
| Earnings Quarterly Growth | 0.202 |
| Earnings Timestamp | 1,777,579,200 |
| Earnings Timestamp End | 1,783,540,800 |
| Earnings Timestamp Start | 1,783,540,800 |
| Ebitda | 12,108,000 |
| Ebitda Margins | 0.16223 |
| Enterprise To Ebitda | 16.989 |
| Enterprise To Revenue | 2.756 |
| Enterprise Value | 205,707,312 |
| Eps Forward | 2.06 |
| Eps Trailing Twelve Months | 3.63 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 61.1082 |
| Fifty Day Average Change | 0.44179916 |
| Fifty Day Average Change Percent | 0.0072297854 |
| Fifty Two Week Change Percent | 36.03721 |
| Fifty Two Week High | 68.99 |
| Fifty Two Week High Change | -7.4399986 |
| Fifty Two Week High Change Percent | -0.1078417 |
| Fifty Two Week Low | 23.47 |
| Fifty Two Week Low Change | 38.08 |
| Fifty Two Week Low Change Percent | 1.622497 |
| Fifty Two Week Range | 23.47 - 68.99 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 523,805,400,000 |
| Float Shares | 1,729,741 |
| Forward Eps | 2.06 |
| Forward P E | 29.878641 |
| Free Cashflow | 5,395,125 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 179 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.27781 |
| Gross Profits | 20,735,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.37112 |
| Held Percent Institutions | 0.32406 |
| Implied Shares Outstanding | 3,192,759 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,751,241,600 |
| Last Split Date | 1,276,819,200 |
| Last Split Factor | 1:3 |
| Long Business Summary | Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. Its products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California. |
| Long Name | Pro-Dex, Inc. |
| Market | us_market |
| Market Cap | 196,514,320 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_298099 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | 12,002,000 |
| Next Fiscal Year End | 1,782,777,600 |
| Non Diluted Market Cap | 201,750,441 |
| Number Of Analyst Opinions | 1 |
| Open | 62.38 |
| Operating Cashflow | 7,342,000 |
| Operating Margins | 0.1551 |
| Overall Risk | 6 |
| Payout Ratio | 0.0 |
| Phone | 949 769 3200 |
| Previous Close | 62.89 |
| Price Hint | 2 |
| Price To Book | 4.3532076 |
| Price To Sales Trailing12 Months | 2.6329343 |
| Profit Margins | 0.1608 |
| Quick Ratio | 2.101 |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -1.34 |
| Regular Market Change Percent | -2.1307 |
| Regular Market Day High | 62.945 |
| Regular Market Day Low | 60.53 |
| Regular Market Day Range | 60.53 - 62.945 |
| Regular Market Open | 62.38 |
| Regular Market Previous Close | 62.89 |
| Regular Market Price | 61.55 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 131,753 |
| Return On Assets | 0.096999995 |
| Return On Equity | 0.29826 |
| Revenue Growth | 0.146 |
| Revenue Per Share | 23.01 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 3 |
| Shares Outstanding | 3,192,759 |
| Shares Percent Shares Out | 0.0466 |
| Shares Short | 148,641 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 143,955 |
| Short Name | Pro-Dex, Inc. |
| Short Percent Of Float | 0.207 |
| Short Ratio | 1.97 |
| Source Interval | 15 |
| State | CA |
| Symbol | PDEX |
| Target High Price | 70.0 |
| Target Low Price | 70.0 |
| Target Mean Price | 70.0 |
| Target Median Price | 70.0 |
| Total Cash | 10,979,000 |
| Total Cash Per Share | 3.439 |
| Total Debt | 20,172,000 |
| Total Revenue | 74,637,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 3.63 |
| Trailing P E | 16.955921 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 45.3619 |
| Two Hundred Day Average Change | 16.188099 |
| Two Hundred Day Average Change Percent | 0.35686553 |
| Type Disp | Equity |
| Volume | 131,753 |
| Website | https://www.pro-dex.com |
| Zip | 92,614 |